Literature DB >> 16410793

Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis.

J R Muppidi1, A A Lobito, M Ramaswamy, J K Yang, L Wang, H Wu, R M Siegel.   

Abstract

Death receptors in the TNF receptor superfamily signal for apoptosis via the ordered recruitment of FADD and caspase-8 to a death-inducing signaling complex (DISC). However, the nature of the protein-protein interactions in the signaling complex is not well defined. Here we show that FADD self-associates through a conserved RXDLL motif in the death effector domain (DED). Despite exhibiting similar binding to both Fas and caspase-8 and preserved overall secondary structure, FADD RDXLL motif mutants cannot reconstitute FasL- or TRAIL-induced apoptosis and fail to recruit caspase-8 into the DISC of reconstituted FADD-deficient cells. Abolishing self-association can transform FADD into a dominant-negative mutant that interferes with Fas-induced apoptosis and formation of microscopically visible receptor oligomers. These findings suggest that lateral interactions among adapter molecules are required for death receptor apoptosis signaling and implicate self-association into oligomeric assemblies as a key function of death receptor adapter proteins in initiating apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410793     DOI: 10.1038/sj.cdd.4401855

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  20 in total

1.  Structural Characterizations of the Fas Receptor and the Fas-Associated Protein with Death Domain Interactions.

Authors:  Urmi Roy
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

Review 2.  The death domain superfamily in intracellular signaling of apoptosis and inflammation.

Authors:  Hyun Ho Park; Yu-Chih Lo; Su-Chang Lin; Liwei Wang; Jin Kuk Yang; Hao Wu
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

3.  Crystal structure of MC159 reveals molecular mechanism of DISC assembly and FLIP inhibition.

Authors:  Jin Kuk Yang; Liwei Wang; Lixin Zheng; Fengyi Wan; Misonara Ahmed; Michael J Lenardo; Hao Wu
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

Review 4.  CD95-mediated cell signaling in cancer: mutations and post-translational modulations.

Authors:  Sébastien Tauzin; Laure Debure; Jean-François Moreau; Patrick Legembre
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

5.  LRRK2 Parkinson disease mutations enhance its microtubule association.

Authors:  Lauren R Kett; Daniela Boassa; Cherry Cheng-Ying Ho; Hardy J Rideout; Junru Hu; Masako Terada; Mark Ellisman; William T Dauer
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

6.  FADD cleavage by NK cell granzyme M enhances its self-association to facilitate procaspase-8 recruitment for auto-processing leading to caspase cascade.

Authors:  S Wang; P Xia; L Shi; Z Fan
Journal:  Cell Death Differ       Date:  2011-10-07       Impact factor: 15.828

7.  Fas stimulation of T lymphocytes promotes rapid intercellular exchange of death signals via membrane nanotubes.

Authors:  Peter D Arkwright; Francesca Luchetti; Julien Tour; Charlotte Roberts; Rahna Ayub; Ana P Morales; José J Rodríguez; Andrew Gilmore; Barbara Canonico; Stefano Papa; Mauro Degli Esposti
Journal:  Cell Res       Date:  2009-09-22       Impact factor: 25.617

Review 8.  Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.

Authors:  Madhu Ramaswamy; Sophia Y Cleland; Anthony C Cruz; Richard M Siegel
Journal:  Results Probl Cell Differ       Date:  2009

9.  Critical role for caspase-8 in epidermal growth factor signaling.

Authors:  Darren Finlay; Amy Howes; Kristiina Vuori
Journal:  Cancer Res       Date:  2009-05-26       Impact factor: 12.701

Review 10.  FLIP as an anti-cancer therapeutic target.

Authors:  Jin Kuk Yang
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.